The Ministry of Health (MoH) has reported on the domestic production of vaccines against the COVID-19, and the receipt and immunisation of vaccines to the Prime Minister.
All the three COVID-19 vaccine candidates Vietnam is developing are currently in the stage of clinical trials, and if they are qualified as assessed by the ethics and advisory councils, the Ministry of Health (MoH) will grant licenses, an official has said.
Deputy Minister of Health Tran Van Thuan held an online working session with France’s Xenothera company on cooperation to conduct the third phase of clinical trial of Xenothera-developed XAV-19 COVID-19 treatment drug and the transfer of XAV-19 production technology to Vietnam.
The National Committee for Ethics in Biomedical Research under the Ministry of Health (MoH) has agreed that the mid-term results from Nano Covax's phase 3 clinical trials will be submitted to the Advisory Council for the Registration of Circulation of Drugs and Medicinal Ingredients for considering the issuance of a registration certificate for the conditional circulation of the vaccine.
Indonesia will soon start human clinical trials of its home-grown COVID-19 vaccine Merah Putih, according to the Food and Drug Supervisory Agency (BPOM).
Vietnam's homegrown Covivac COVID-19 vaccine is being injected to volunteers Thai Binh province’s Vu Thu district from August 18 during its second phase clinical trials.
Vietnam's homegrown Covivac COVID-19 vaccine is being injected to volunteers from the communes of Minh Lang, Viet Hung and Bach Thuan in Thai Binh province’s Vu Thu district from August 18 during its second phase clinical trials.
The Hanoi Medical University will start on August 15 Phase 1 of clinical trial of the mRNA COVID-19 vaccine named ARCT-154 vaccine with 100 volunteers from Hanoi.
The Hanoi Medical University will on August 15 start the first phase of clinical trials of COVID-19 vaccine ARCT-154, a mRNA vaccine developed by US company Arcturus Therapeutics, Inc, which transferred the technology to a company in Vietnam.
Vietnam’s second homegrown candidate vaccine Covivac has began the second stage of clinical trials with the screening testing to choose qualified volunteers.
Vietnam’s second homegrown candidate vaccine Covivac began the second stage of clinical trials in the northern province of Thai Binh’s Vu Thu district on August 11 with the screening testing to choose qualified volunteers.
The Ministry of Health in collaboration with the World Health Organisation organized a webinar on August 4 to consult experts on the evaluation of clinical research data and approval of vaccines against COVID-19 in emergency situations.
All types of COVID-19 vaccine approved by Vietnam for emergency use have gone through three stages of clinical trials, the Health Ministry has affirmed.
The clinical trials of Vietnamese COVID-19 vaccine candidate Nano Covax are set to enter Phase 3 this month with the optimal dosage of 25mcg, aiming to further test the safety and efficacy of the vaccine in humans before mass production begins.
Two COVID-19 vaccines Nano Covax and Covivac, which were studied and developed in Vietnam, have proved to be safe and effective in the first and second clinical trials.
Nearly 300 volunteers in the Mekong Delta province of Long An are set to receive injections of Nano Covax in the second-stage human clinical trials of the COVID-19 vaccine candidate from Vietnam.